Zimmer Biomet Holdings (ZBH) Operating Expenses (2009 - 2026)

Zimmer Biomet Holdings' Operating Expenses history runs 18 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• On a quarterly basis, Operating Expenses rose 5.98% year-over-year to $1.7 billion in Q1 2026; TTM through Mar 2026 was $7.2 billion, a 13.21% increase from a year earlier, with the FY2025 full-year figure at $7.1 billion, up 11.58% from the prior year.
• Operating Expenses eased to $1.7 billion in Q1 2026 per ZBH's latest filing, from $2.1 billion in the prior quarter.
• Across five years, Operating Expenses topped out at $2.1 billion in Q4 2025 and bottomed at $1.4 billion in Q3 2022.
• The 5-year median for Operating Expenses is $1.6 billion (2024), against an average of $1.6 billion.
• Across the five-year window, Operating Expenses fell 14.43% in 2023 and increased 27.84% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $1.9 billion in 2022, then declined by 14.43% to $1.6 billion in 2023, then grew by 3.05% to $1.6 billion in 2024, then advanced by 27.84% to $2.1 billion in 2025, then declined by 17.99% to $1.7 billion in 2026.
• Per Business Quant, the three latest ZBH Operating Expenses figures stand at $1.7 billion (Q1 2026), $2.1 billion (Q4 2025), and $1.7 billion (Q3 2025).